Affordable Access

Therapeutic Potential of Autologous Adipose-Derived Stem Cells for the Treatment of Liver Disease

Authors
  • Gardin, Chiara
  • Ferroni, Letizia
  • Bellin, Gloria
  • Rubini, Giuseppe
  • Barosio, Simone
  • Zavan, Barbara
Publication Date
Dec 15, 2018
Source
MDPI
Keywords
Language
English
License
Green
External links

Abstract

as a consequence, dogs may be a spontaneous model for clinical investigations in humans. The aim of this work was to characterize canine adipose-derived MSCs (cADSCs) and compare them to their human counterpart (hADSCs) in order to support the application of the canine model in cell-based therapy of liver diseases. Both cADSCs and hADSCs were successfully isolated from adipose tissue samples. The two cell populations shared a common fibroblast-like morphology, expression of stemness surface markers, and proliferation rate. When examining multilineage differentiation abilities, cADSCs showed lower adipogenic potential and higher osteogenic differentiation than human cells. Both cell populations retained high viability when kept in PBS at controlled temperature and up to 72 h, indicating the possibility of short-term storage and transportation. In addition, we evaluated the efficacy of autologous ADSCs transplantation in dogs with liver diseases. All animals exhibited significantly improved liver function, as evidenced by lower liver biomarkers levels measured after cells transplantation and evaluation of cytological specimens. These beneficial effects seem to be related to the immunomodulatory properties of stem cells. We therefore believe that such an approach could be a starting point for translating the results to the human clinical practice in future.

Report this publication

Statistics

Seen <100 times